Russell A. Barkley - Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments

Original price was: $149.99.Current price is: $28.00.

[Instant Download] – Immediately deliver the download link after receiving the payment

Purchase this course you will earn 28 Points worth of $2.80

Category: Uncategorized

Description

Ready to Master Russell A. Barkley – Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments ? Buy Now at Utralist & Save Big (Up to 80%)! Get step-by-step guidance and lifetime access. Start learning today!

[Instant Download] – Immediately deliver the download link after receiving the payment

Purchase Russell A. Barkley – Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments courses at here with PRICE ~~$149.99~~ $28

Faculty:: Russell A. Barkley
Duration:: 3 Hours
Format:: Audio and Video
Copyright:: Aug 28, 2018

Description

Outline

Purpose of medication interventions

Stimulant medications most effective and well researched ADHD interventions
Safety, convenience and cost effectiveness are well established

Mechanisms of action for the three categories of ADHD medications Neurobiological mechanism of operation

Traditional stimulants as compared to new alpha-2a receptor conceptualizations

Primary US approved stimulant medications

Efficacy and factors in noncompliance
New developments in delivery systems
OROS, Pulse delivery, transdermal, lisdexamfetamine

Stimulant efficacy in preschoolers

Gains smaller, side effects greater than in older children

Behavioral benefits of stimulant interventions

Academic, temperamental

Primary side effects of stimulant interventions

Insomnia, appetite suppression, head ache, gastric distress, cardiac effects

Common misconceptions related to stimulant use Predictors of positive response to medications Newer medication interventions

Atomoxetine – positive and side effects, rationale for use
Guanfacine XR – positive and side effects, rationale for use

Importance of early intervention in ADHD

Neuroprotective effects

Off label medications used for ADHD Factors involved in choosing which medication to use

Intervention context, patient characteristics, comorbidity

Conclusions

Evidence based treatments
Experimental psychosocial treatments
Nutritional interventions
Disproven therapies

Faculty

Russell A. Barkley, Ph.D. Related seminars and products: 14

Russell A. Barkley, Ph.D., is a Clinical Professor of Psychiatry at the Virginia Treatment Center for Children and Virginia Commonwealth University Medical Center, Richmond, VA. He is a Diplomate (board certified) in three specialties, Clinical Psychology (ABPP), Clinical Child and Adolescent Psychology, and Clinical Neuropsychology (ABCN, ABPP). Dr. Barkley is a clinical scientist, educator, and practitioner who has published 23 books, rating scales, and clinical manuals numbering 41 editions. He has also published more than 270 scientific articles and book chapters related to the nature, assessment, and treatment of ADHD and related disorders and is the author of the book Managing ADHD in School (PESI, 2016).

He is the founder and editor of the bimonthly clinical newsletter, The ADHD Report, now in its 25th year of publication. Dr. Barkley has presented more than 800 invited addresses internationally and appeared on nationally televised programs such as 60 Minutes, the Today Show, Good Morning America, CBS Sunday Morning, CNN, and many other programs on behalf of those with ADHD. He has received awards from the professional societies and ADHD organizations for his lifetime achievements, career accomplishments, contributions to research in ADHD, to clinical practice, and for the dissemination of science. His websites are russellbarkley.org and ADHDLectures.com.

Speaker Disclosures:

Financial: Dr. Russell Barkley is employed by the Medical University of South Carolina. He is on the speaker’s bureau for Eli Lilly and receives compensation. He has an advisory board relationship with Theravance and receives compensation. He is an author for Guilford Press and receives royalties. He is an author for Jones and Bartlett Publishers and receives royalties. He is a speaker for J&K Seminar and receives royalties. He is a speaker for PsychContinuingEd.com and receives royalties. He is a speaker for ContinuingEdCourse.com and receives royalties. He is a speaker who receives an honorarium for PESI, Inc.

Non-Financial: Dr. Russell Barkley has no relevant non-financial relationship to disclose.

Salepage: https://catalog.pesi.com//item/advances-management-adhd-evidencebased-medications-psychosocial-treatments-33906

Archive: https://archive.ph/OHKEH

Purchase Russell A. Barkley – Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments courses at here with PRICE ~~$149.99~~ ~~$28~~

Why Choose the Top-Rated Russell A. Barkley – Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments Course on Utralist?

The Russell A. Barkley – Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments course on Utralist is a highly sought-after online program designed for mastery. Gain practical skills through a unique learning experience led by industry experts.

🔑 Key Benefits:

Expert-Led Training: Learn from top industry professionals.
Easy-to-Follow Lessons: Actionable insights for quick understanding.
Flexible Learning: Study at your own pace, anytime, anywhere.
Certificate of Completion: Showcase your new skills and boost your resume.

💬 Frequently Asked Questions:

Is the Russell A. Barkley – Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments course secure? Yes, our platform uses top-tier encryption for 100% data and transaction security.
How do I access the course after purchase? Get instant access to download materials or study online via your account dashboard.
What if I need help? Visit our Contact Us page for dedicated support.